HIV controllers: a genetically determined or inducible phenotype?, Immunological Reviews, vol.473, issue.1, pp.281-294, 2013. ,
DOI : 10.1111/imr.12076
URL : https://hal.archives-ouvertes.fr/pasteur-01420535
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, vol.107, issue.12, pp.4781-4789, 2006. ,
DOI : 10.1182/blood-2005-12-4818
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895811
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nature Immunology, vol.3, issue.11, pp.1061-1068, 2002. ,
DOI : 10.1038/ni845
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype, Proceedings of the National Academy of Sciences, vol.104, issue.16, pp.6776-6781, 2007. ,
DOI : 10.1073/pnas.0611244104
URL : https://hal.archives-ouvertes.fr/pasteur-00142658
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity, Proceedings of the National Academy of Sciences, vol.98, issue.9, pp.5140-5145, 2001. ,
DOI : 10.1073/pnas.071548198
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV, 2000. ,
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Science, vol.330, pp.1551-1557, 2010. ,
Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers, Journal of Virology, vol.88, issue.1, pp.176-18702098, 2014. ,
DOI : 10.1128/JVI.02098-13
URL : https://hal.archives-ouvertes.fr/pasteur-01420526
Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses, The Journal of Immunology, vol.182, issue.12, pp.7828-7837, 2009. ,
DOI : 10.4049/jimmunol.0803928
ABSTRACT, Journal of Virology, vol.89, issue.7, pp.3542-355603723, 2015. ,
DOI : 10.1128/JVI.03723-14
Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection, PLoS ONE, vol.77, issue.3, p.321, 2007. ,
DOI : 10.1371/journal.pone.0000321.t001
Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses, Journal of Virology, vol.86, issue.12, pp.6959-696900531, 2012. ,
DOI : 10.1128/JVI.00531-12
Isolation and characterization of replication-competent human immunodeficiency virus type 1, 2007. ,
Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study), AIDS, vol.21, issue.8, pp.1043-1045, 2007. ,
DOI : 10.1097/QAD.0b013e3280d5a7ac
URL : https://hal.archives-ouvertes.fr/hal-00166186
Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes, Journal of Virology, vol.82, issue.17, pp.8422-843000535, 2008. ,
DOI : 10.1128/JVI.00535-08
HIV cure and eradication: how will we get from the laboratory to effective clinical trials?, AIDS, vol.25, issue.7, pp.885-897, 2011. ,
DOI : 10.1097/QAD.0b013e3283467041
Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers, Blood, vol.118, issue.4, pp.955-964, 2011. ,
DOI : 10.1182/blood-2010-12-327106
URL : https://hal.archives-ouvertes.fr/pasteur-01420583
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1, Proceedings of the National Academy of Sciences, vol.111, issue.37, pp.13475-13480, 2014. ,
DOI : 10.1073/pnas.1406663111
A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control, AIDS, vol.29, issue.15, pp.2003-2007 ,
DOI : 10.1097/QAD.0000000000000734
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy, Antiviral Therapy, vol.17, issue.6, pp.1001-1009, 2012. ,
DOI : 10.3851/IMP2273
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection, AIDS, vol.24, issue.10, pp.1598-1601, 2010. ,
DOI : 10.1097/QAD.0b013e32833b61ba
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions, AIDS, vol.18, issue.14, pp.1951-1953, 2004. ,
DOI : 10.1097/00002030-200409240-00011
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation, Annals of Internal Medicine, vol.161, issue.5, pp.319-327, 2014. ,
DOI : 10.7326/M14-1027
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection, PLoS ONE, vol.4, issue.6, p.6093, 2009. ,
DOI : 10.1371/journal.pone.0006093.s008
URL : https://hal.archives-ouvertes.fr/hal-00464770
Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.4, pp.380-388, 2007. ,
DOI : 10.1097/QAI.0b013e3180640cf5
LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01), J Med Virol, vol.81, pp.217-223, 2009. ,
HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors, AIDS, vol.22, issue.14, pp.1880-1882, 2008. ,
DOI : 10.1097/QAD.0b013e32830fbdbc
In???Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection, PLoS ONE, vol.83, issue.2, 2012. ,
DOI : 10.1371/journal.pone.0032714.s001
Replicative capacity of human HIV-1 Control and Frequency of Infected Cells, 2010. ,
Ex vivo T cell???based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses, Nature Protocols, vol.178, issue.6, pp.1033-1041, 2010. ,
DOI : 10.1038/nprot.2006.268
URL : https://hal.archives-ouvertes.fr/pasteur-01420584
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure, Cell, vol.155, issue.3, pp.540-551, 2013. ,
DOI : 10.1016/j.cell.2013.09.020
Ex vivo analysis identifies effective HIV-1 latency???reversing drug combinations, Journal of Clinical Investigation, vol.125, issue.5, 1901. ,
DOI : 10.1172/JCI80142DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463209
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression, PLOS Pathogens, vol.81, issue.463, p.1005063 ,
DOI : 10.1371/journal.ppat.1005063.s009
Regulation of JAK???STAT signalling in the immune system, Nature Reviews Immunology, vol.3, issue.11, pp.900-911, 2003. ,
DOI : 10.1038/nri1226
Prostratin Antagonizes HIV Latency by Activating NF-??B, Journal of Biological Chemistry, vol.279, issue.40, pp.42008-42017, 2004. ,
DOI : 10.1074/jbc.M402124200
HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription, PLoS Pathogens, vol.14, issue.10, pp.1459-1469, 2007. ,
DOI : 0890-9369(2000)014[2314:TGRINB]2.0.CO;2
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation, PLoS Pathogens, vol.20, issue.6, 2009. ,
DOI : 10.1371/journal.ppat.1000495.s009
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients, AIDS, vol.26, issue.12, pp.1473-1482, 2012. ,
DOI : 10.1097/QAD.0b013e32835535f5
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid, AIDS Research and Human Retroviruses, vol.25, issue.2, pp.207-212, 2009. ,
DOI : 10.1089/aid.2008.0191
Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus, Journal of Virology, vol.84, issue.14, pp.7018-7028, 2010. ,
DOI : 10.1128/JVI.00548-10
Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy, The Journal of Infectious Diseases, vol.197, issue.4, pp.563-571, 2008. ,
DOI : 10.1086/526786
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study, PLoS Pathogens, vol.22, issue.16, p.1003211, 2013. ,
DOI : 10.1371/journal.ppat.1003211.s007
URL : https://hal.archives-ouvertes.fr/pasteur-01420534
Enhanced Anti-HIV Functional Activity Associated with Gag-Specific CD8 T-Cell Responses, Journal of Virology, vol.84, issue.11, pp.5540-554902031, 2010. ,
DOI : 10.1128/JVI.02031-09
Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection, Journal of Infectious Diseases, vol.211, issue.11, pp.1692-1702, 2015. ,
DOI : 10.1093/infdis/jiu809
Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers, PLoS Pathogens, vol.3, issue.10, p.1003691, 2013. ,
DOI : 10.1371/journal.ppat.1003691.t001
CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory, PLoS ONE, vol.4, issue.9, 2011. ,
DOI : 10.1371/journal.pone.0018726.t002
URL : https://hal.archives-ouvertes.fr/pasteur-01420582
Effect of Antiretroviral Therapy on HIV Reservoirs in Elite Controllers, Journal of Infectious Diseases, vol.208, issue.9, pp.1443-1447, 2013. ,
DOI : 10.1093/infdis/jit306
Absence of HIV-1 after treatment cessation in an infant, N Engl J Med, vol.370, p.678, 2014. ,
ABSTRACT, Journal of Virology, vol.89, issue.21, pp.10735-1074701527, 2015. ,
DOI : 10.1128/JVI.01527-15
Patients, AIDS Research and Human Retroviruses, vol.26, issue.5, pp.553-558, 2010. ,
DOI : 10.1089/aid.2009.0256
CD4 Cell Count and HIV DNA Level Are Independent Predictors of Disease Progression after Primary HIV Type 1 Infection in Untreated Patients, Clinical Infectious Diseases, vol.42, issue.5, pp.709-715, 2006. ,
DOI : 10.1086/500213
T Cell Counts, The Journal of Infectious Diseases, vol.192, issue.1, pp.46-55, 2005. ,
DOI : 10.1086/430610
URL : https://hal.archives-ouvertes.fr/pasteur-01420524
Integrated and total HIV-1 DNA predict ex vivo viral outgrowth, PLoS Pathog, vol.12, 2016. ,
DOI : 10.1371/journal.ppat.1005472
URL : http://doi.org/10.1371/journal.ppat.1005472
A Cell-Intrinsic Inhibitor of HIV-1 Reverse Transcription in CD4+ T Cells from Elite Controllers, Cell Host & Microbe, vol.15, issue.6, pp.717-728, 2014. ,
DOI : 10.1016/j.chom.2014.05.011
Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs, Nature Communications, vol.78, p.716, 2012. ,
DOI : 10.1038/ncomms1697